# 约翰氏病诊断市场

> 约翰氏病诊断市场研究报告按检测类型（血清学检测、PCR检测、培养检测、嵌套PCR检测）、按动物类型（牛、羊、山羊、鹿）、按最终用户（兽医诊所、诊断实验室、研究机构）、按分销渠道（在线药房、直接销售、零售药房）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.18%
- **2024:** $ 0.79 Billion
- **2025:** $ 0.84 Billion
- **2035:** $ 1.53 Billion
- **Key Players:** IDEXX Laboratories (US), Neogen Corporation (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Herd Health (CA), Zoetis (US), Merck Animal Health (US), QIAGEN (DE), Genetic Technologies (AU)

**Report ID:** MRFR/MED/30894-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/johnes-disease-diagnostic-market-32693

---

## Market Summary

## **Johne's Disease Diagnostic Market Overview**

As per MRFR analysis, the Johne’s Disease Diagnostic Market Size was estimated at 0.79 (USD Billion) in 2024. The Johne’s Disease Diagnostic Market Industry is expected to grow from 0.84 (USD Billion) in 2025 to 1.44 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.18% during the forecast period (2025 - 2034).

## **Key Johne's Disease Diagnostic Market Trends Highlighted**

The Johne's Disease Diagnostic Market is primarily driven by an increasing awareness of animal health and welfare, especially in livestock. The growing incidence of Johne's disease among ruminants has prompted livestock producers and veterinarians to seek effective diagnostics to manage and prevent the disease.

Enhanced regulatory frameworks and quality standards in the food industry are pushing stakeholders to adopt proactive measures, thereby increasing the demand for reliable diagnostic tools. Furthermore, advancements in testing technologies and the rise of personalized veterinary care also act as significant contributors to market growth.

Opportunities abound for companies in this market, particularly in developing rapid and cost-effective diagnostic solutions. The expansion of the livestock industry in emerging economies presents a significant opportunity as farmers and veterinarians in these regions become more aware of the implications of Johne's disease.

Collaborations between diagnostic companies and research institutions can lead to the development of innovative solutions tailored to specific market needs. Additionally, the rising focus on preventive healthcare in livestock management signals the potential for growth as farmers look to minimize disease outbreaks and enhance herd productivity.

Recently, the market has seen trends toward multiplex testing methods that enable the simultaneous detection of multiple pathogens, including those causing Johne's disease. There is also an increasing interest in developing molecular diagnostic techniques, such as PCR, that offer higher sensitivity and specificity compared to traditional methods. The use of point-of-care testing is gaining traction, facilitating quicker diagnosis and treatment decisions for veterinarians.

Digital transformation in veterinary diagnostics, along with the integration of telemedicine, has influenced the market, making it easier for professionals to access diagnostic services.Overall, the market is evolving with a clear focus on innovative diagnostic solutions, reflecting a commitment to improving animal health and welfare.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Johne's Disease Diagnostic Market Drivers**

### **Rising Awareness and Diagnosis of Johne's Disease**

The increasing awareness about Johne's disease among farmers, veterinarians, and livestock owners is significantly driving the Johne's Disease Diagnostic Market Industry. As more stakeholders recognize the impact of the disease on livestock health and agricultural productivity, there is a growing demand for effective diagnostic tools. This disease can lead to substantial economic losses, prompting the need for early detection and management.

The ongoing shift toward preventive healthcare and biosecurity measures in animal husbandry is further amplifying this trend. The Johne's Disease Diagnostic Market Industry is thus witnessing an influx of innovation aimed at improving diagnostic accuracy and ease of use, bolstered by both public and private sector initiatives aimed at facilitating better animal health practices globally.

### **Technological Advances in Diagnostic Tools**

Advancements in diagnostic technologies have been a major catalyst for growth in the Johne's Disease Diagnostic Market Industry. New testing methodologies, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assays (ELISA), offer increased sensitivity and specificity, allowing for earlier and more reliable detection of Johne's disease. These innovations enhance the ability of veterinarians and livestock owners to identify infected animals promptly, minimizing the spread of the disease.

Furthermore, the development of portable diagnostic devices enables rapid testing in the field, making it easier for farmers to get timely results. This trend toward enhanced diagnostic capabilities is expected to drive market growth as stakeholders increasingly seek efficient and reliable solutions for managing animal health.

### **Government Support and Regulatory Frameworks**

Government initiatives and regulatory frameworks play a crucial role in propelling the Johne's Disease Diagnostic Market Industry forward. Many countries are implementing policies aimed at improving animal health and biosecurity, which directly relates to the management of Johne's disease. Financial support and grants for research and development in diagnostic technologies are becoming more common, encouraging innovation in this field. Additionally, regulations requiring testing and monitoring of livestock health create a structured demand for diagnostic solutions.

As governments continue to prioritize animal welfare and public health, compliance with testing protocols will further enhance the market landscape.

## **Johne's Disease Diagnostic Market Segment Insights**

### **Johne's Disease Diagnostic Market Test Type Insights **

The Johne's Disease Diagnostic Market reflects significant growth driven largely by advancements in diagnostic technologies and the rising incidence of Johne's Disease in livestock. In 2023, the market was valued at 0.7 USD Billion, with a noteworthy segmentation that highlights different test types being employed to diagnose this disease, which primarily affects cattle and can significantly impact dairy production.

Among these test types, Serological Tests hold a majority stake in the market, valued at 0.25 USD Billion in 2023 and growing to 0.4 USD Billion by 2032. These tests are essential as they provide vital data about the presence of antibodies in animals, making them a crucial tool for herd management and disease control strategies

Additionally, PCR Tests, valued at 0.2 USD Billion in 2023, play an important role as they offer rapid and specific diagnosis by detecting the DNA of the pathogen responsible for Johne's Disease. This segment reached 0.35 USD Billion in 2032, reflecting its increasing adoption due to the need for quick and accurate results in clinical settings.

Culture Tests, while holding a smaller market valuation of 0.15 USD Billion in 2023, are significant for confirming the presence of Mycobacterium avium subspecies paratuberculosis, the bacterium that causes Johne's Disease. Despite its smaller footprint, the reliability of Culture Tests in providing definitive diagnosis sustains its relevance in the market, projecting growth to 0.25 USD Billion by 2032

Lastly, Nested PCR Tests, which are valued at 0.1 USD Billion in 2023, are critical for enhancing the sensitivity and specificity of the diagnostic tests, allowing for improved detection rates in complicated cases and reaching a valuation of 0.2 USD Billion by 2032. The overall growth trends observed within the Johne's Disease Diagnostic Market revenue signify growing awareness about livestock health, the necessity of early intervention, and the importance of employing multiple diagnostic strategies

Each test type serves its unique purpose, contributing to a holistic approach toward managing Johne's Disease, thus providing robust opportunities for market expansion as livestock producers increasingly prioritize animal health and biosecurity measures. The market dynamics encapsulated within this segment showcase a blend of innovation and necessity, reinforcing the critical role of continuous advancements in diagnostic methodologies while addressing underlying challenges such as disease management and prevention in livestock farming.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Johne's Disease Diagnostic Market Animal Type Insights **

The Johne's Disease Diagnostic Market, focusing on the Animal Type segment, plays a crucial role in veterinary diagnostics and agricultural economics. In 2023, the market was valued at 0.7 billion USD, showcasing significant activity within the industry. Major animal categories include Cattle, Sheep, Goats, and Deer, each contributing to the overall market dynamics.

Cattle often dominate this segment due to their economic importance in livestock production and dairy farming, wherein early detection of Johne's disease helps improve herd health and farm profitability.

Additionally, Sheep and Goats are also important, particularly in regions where small ruminants are prevalent in agriculture. Effective diagnostics for these animals can lead to better herd management and decrease transmission risks. Additionally, Deer represents a growing interest as farmed deer populations increase, highlighting the need for specific diagnostic solutions tailored to their health.

The increasing prevalence of Johne's disease, combined with rising awareness of animal health, drives the demand for enhanced diagnostic technologies, indicating promising growth opportunities within the market.The expected market growth reflects a broader trend of prioritizing animal welfare and disease prevention in livestock management.

### **Johne's Disease Diagnostic Market End User Insights **

The Johne's Disease Diagnostic Market is experiencing significant growth was, valued at 0.7 USD Billion in 2023. Various end-users are pivotal in driving this growth, including [veterinary clinics](../../../reports/veterinary-medicine-market-844), diagnostic laboratories, and research institutes. Veterinary clinics play a crucial role in providing diagnostics directly to pet owners and farmers, helping manage and prevent Johne's disease in livestock and companion animals. Diagnostic laboratories are essential for conducting detailed tests and analyses, facilitating accurate diagnoses that guide treatment protocols.

Research institutes also hold a significant position as they focus on developing innovative diagnostic solutions and understanding disease mechanisms, contributing to improved overall market growth and advancements. The segmentation of the Johne's Disease Diagnostic Market highlights the importance of these end-users in the ongoing effort to combat this disease, reflecting growing awareness and demand for effective diagnostic solutions. As a result, the market is expected to leverage advancements in technology and research, paving the way for new opportunities and enhanced market dynamics in the forthcoming years.

### **Johne's Disease Diagnostic Market Distribution Channel Insights **

The Johne's Disease Diagnostic Market was valued at 0.7 billion USD in 2023, highlighting its increasing importance within the healthcare sector. Within the Distribution Channel sector, variations like Online Pharmacies, Direct Sales, and Retail Pharmacies play crucial roles in how diagnostic solutions reach end-users.

Online Pharmacies have gained traction due to the convenience of accessing products remotely, enhancing market penetration and consumer reach. Direct Sales allow for tailored customer interactions that can foster loyalty and trust, making it a preferred choice among certain demographics.

Meanwhile, Retail Pharmacies dominate the market's physical presence, offering immediate product availability and personal customer service, which are vital in healthcare decision-making. Together, these channels create a comprehensive approach to distributing Johne's Disease diagnostics, ultimately contributing to the Johne's Disease Diagnostic Market revenue and influencing overall market growth through varied consumer preferences and accessibility options. The growing awareness of Johne's Disease among farmers and veterinarians, along with advancements in diagnostic technologies, further drives the segmentation's importance in achieving comprehensive market objectives.

### **Johne's Disease Diagnostic Market Regional Insights **

The Johne's Disease Diagnostic Market revenue demonstrates structured growth across various regions, with North America leading the way. In 2023, North America held a valuation of 0.25 USD Billion, expected to rise to 0.43 USD Billion by 2032, thus showcasing a significant dominance in the market. Europe closely followed with a 2023 value of 0.20 USD Billion and a future projection of 0.35 USD Billion, indicating a robust presence in Johne's disease diagnostics. APAC is positioned at 0.15 USD Billion initially and is anticipated to reach 0.28 USD Billion, reflecting growing awareness and investment in veterinary diagnostics.

South America and MEA, though smaller in comparison with market values of 0.05 USD Billion and 0.07 USD Billion, respectively, in 2023, show potential for growth driven by increasing livestock health initiatives. The majority held by North America and Europe is due to their established healthcare infrastructure and research advancements, driving market growth in the Johne's Disease Diagnostic Market.

Additionally, the rising emphasis on livestock disease prevention practices presents notable opportunities, while challenges may arise from limited awareness in less dominant regions.Such dynamics contribute to the overall Johne's Disease Diagnostic Market statistics, showcasing a diversified regional landscape.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Johne's Disease Diagnostic Market Key Players and Competitive Insights:**

The Johne's Disease Diagnostic Market has garnered significant attention owing to the increasing awareness of Johne's disease, a chronic infection in livestock that can severely impact dairy and beef production. As a result, various stakeholders are focusing on enhancing diagnostic tools and techniques for early detection and management of this disease. Competitive insights in this market reveal a landscape filled with key players striving to innovate and meet the growing demand for effective diagnostic solutions

. These companies are integrating advanced technologies into their products, expanding their geographical reach, and forming strategic partnerships to strengthen their market position. The competitive dynamics are also shaped by regulatory requirements and the need for reliable, fast, and accurate diagnostic tests, creating opportunities for both established firms and new entrants.

IDEXX Laboratories stands out in the Johne's Disease Diagnostic Market due to its robust portfolio of diagnostic products and solutions tailored for veterinary applications. The company's strengths lie in its continuous commitment to innovation and research, enabling it to deliver high-quality diagnostics that are integral for controlling the spread of Johne's disease in cattle. With a strong focus on customer support and training programs, IDEXX Laboratories has established itself as a trusted partner among veterinarians and livestock producers.

Furthermore, IDEXX's established global presence allows it to leverage extensive distribution networks, ensuring that its diagnostic products reach a wide array of customers. The brand's ability to integrate digital solutions with traditional diagnostic methods enhances its appeal, making it a formidable competitor in the market.

Epitopix is another notable player in the Johne's Disease Diagnostic Market, recognized for its specialized focus on diagnostic solutions that cater specifically to Johne's disease and other infectious diseases in livestock. With a focus on addressing the unique challenges facing livestock producers, Epitopix continues to enhance its product offerings, thereby strengthening its competitive edge in the Johne's disease diagnostic sector.

## **Key Companies in the Johne's Disease Diagnostic Market Include:**

- IDEXX Laboratories
- Epitopix
- Merck Animal Health
- Randox Laboratories
- QIAGEN
- BioRad Laboratories
- Zoetis
- Neogen Corporation
- **[Thermo Fisher Scientific](https://www.thermofisher.com/in/en/home/industrial/animal-health/bovine-cattle-diagnostic-solutions/bovine-diseases/map-paratuberculosis.html)**
- Agilent Technologies
- Boehringer Ingelheim
- Parker Agribusiness
- Virbac
- Alere Inc.
- Herd Navigator

### **Johne's Disease Diagnostic Industry Developments**

Recent developments in the Johne's Disease Diagnostic Market indicate significant progress and growing interest in improving diagnostic capabilities among key industry players. Companies such as IDEXX Laboratories and Zoetis have been actively enhancing their testing solutions to provide faster and more accurate diagnosis of Johne's Disease in livestock. Additionally, Epitopix and Merck Animal Health are focusing on developing innovative serological tests, which are crucial for early detection and management strategies.

Recent market dynamics have highlighted increased investments from corporations such as QIAGEN and Thermo Fisher Scientific, driving advancements in molecular diagnostics technologies. Furthermore, BioRad Laboratories and Neogen Corporation are exploring collaboration opportunities for developing comprehensive testing portfolios.

In terms of mergers and acquisitions, there has been notable activity with companies expanding their diagnostics capabilities through strategic partnerships, bolstering their presence in the market. This ongoing consolidation is expected to enhance their technological offerings and broaden their market reach. The overall growth and investment in the Johne's Disease Diagnostic Market reflect a heightened focus on animal health and food safety, driven by an increasing awareness of the economic impacts associated with this disease in livestock production.

## **Johne's Disease Diagnostic Market Segmentation Insights**

### **Johne's Disease Diagnostic Market Test Type Outlook**

- Serological Tests
- PCR Tests
- Culture Tests
- Nested PCR Tests

## **Johne's Disease Diagnostic Market Animal Type Outlook**

- Cattle
- Sheep
- Goats
- Deer

### **Johne's Disease Diagnostic Market End User Outlook**

- Veterinary Clinics
- Diagnostic Laboratories
- Research Institutes

### **Johne's Disease Diagnostic Market Distribution Channel Outlook**

- Online Pharmacies
- Direct Sales
- Retail Pharmacies

### **Johne's Disease Diagnostic Market Regional Outlook**

- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa

## Market Drivers

### Regulatory Framework and Guidelines

建立约内氏病管理的监管框架和指南是约内氏病诊断市场的关键驱动力。多个国家正在实施政策，强制对牲畜进行约内病检测和控制措施。这些法规旨在保护公众健康并确保来自受影响动物的食品的安全。遵守这些法规通常需要使用诊断测试，从而增加了对可靠诊断解决方案的需求。此外，兽医协会制定的最佳实践指南正在鼓励生产商采取主动检测策略。随着利益相关者寻求符合合规要求并改善牛群健康，这种监管支持可能会促进市场增长。

### Rising Prevalence of Johne's Disease

家畜（尤其是牛）中约内氏病发病率的增加是约内氏病诊断市场的主要驱动力。报告表明，该疾病影响了很大一部分奶牛群，估计某些地区高达 68% 的奶牛群可能受到影响。这种不断上升的患病率需要有效的诊断工具来管理和控制该疾病，从而推动市场增长。农民和兽医越来越认识到约翰氏病的经济影响，它可能导致牛奶产量减少和兽医成本增加。因此，随着利益相关者寻求实施有效的管理策略以减轻疾病对牲畜健康和生产力的影响，对可靠诊断解决方案的需求预计将会增加。

### Increased Investment in Animal Health

对动物健康和福利的日益重视正在显着影响约内氏病诊断市场。公共和私营部门对兽医卫生举措的投资增加正在促进创新诊断解决方案的开发。各国政府和组织正在认识到控制约翰氏病以确保食品安全和动物福利的重要性。这导致了旨在支持诊断技术研究和开发的资助计划的建立。此外，消费者对优质动物产品的需求不断增长，促使生产商采取严格的健康管理措施，包括定期检测约内氏病。因此，在这些投资和对动物健康的高度关注的推动下，市场可能会经历持续增长。

### Advancements in Diagnostic Technologies

诊断方法的技术创新正在改变约内病诊断市场。 PCR、ELISA等先进分子技术的引入，提高了诊断的准确性和速度。这些方法可以及早检测鸟分枝杆菌副结核亚种（约内氏病的病原体），这对于有效的牛群管理至关重要。市场正在见证向更复杂的诊断工具的转变，这些工具具有更高的灵敏度和特异性。随着这些技术变得更容易获得和负担得起，它们可能会推动兽医和牲畜生产者的采用。此外，数据管理和分析数字平台的集成预计将简化诊断流程，从而促进市场增长。

### Growing Awareness Among Livestock Producers

畜牧生产者对约翰病影响的认识不断提高，对约翰病诊断市场产生了重大影响。教育举措和推广计划正在让生产者了解该疾病的经济和健康后果。随着意识的提高，生产者更倾向于投资于诊断测试，以识别和管理牛群中受感染的动物。这种思维方式的转变正在促进采取积极主动的疾病管理方法，这对于维持牛群生产力和盈利能力至关重要。此外，兽医专业人员的资源和支持进一步鼓励生产商优先考虑检测和控制措施。因此，这种日益增长的意识预计将推动市场对诊断解决方案的需求。

## Future Outlook

约翰氏病诊断市场预计将在2024年至2035年间以6.18%的年复合增长率增长，推动因素包括意识的提高和诊断技术的进步。

**New opportunities:**

- 快速现场检测工具的开发

到2035年，市场预计将实现显著增长，提升全球的诊断能力。

## Segment Insights

### 按测试类型：PCR 测试（最大）与血清学测试（增长最快）

在约翰氏病诊断市场中，PCR 检测因其高精度和快速结果而占据最大的市场份额。紧随其后的是，血清学检测由于其易用性和较低的成本而成为增长最快的领域，可满足更广泛的兽医诊断需求。培养测试和巢式 PCR 测试虽然必不可少，但相比之下所占份额较小，这突显了在对抗约内氏病时对分子诊断的偏好的转变。

血清学测试（主导）与培养测试（新兴）

由于有效性和成本效益的结合，血清学检测目前是诊断约尼氏病的主要选择，为兽医和牲畜所有者提供了可靠的筛查方法。另一方面，培养测试虽然被认为是一种新兴选择，但可以提供明确的诊断，但需要更多的时间和技术专业知识，因此不太容易获得。由于兽医实践以效率为目标，对快速、可靠测试的偏好凸显了市场的竞争本质，鼓励了技术和方法的进步。

### 按动物类型：牛（最大）与羊（生长最快）

在约翰氏病诊断市场中，“动物类型”细分市场的市场份额分布存在显着差异。牛所占比例最大，主要是因为它们的约内氏病患病率较高，因此需要严格的诊断测试。与此同时，由于人们对约翰氏病及其对牲畜健康和生产力的影响的认识不断提高，绵羊正在成为增长最快的部分。随着农民和兽医更加关注疾病管理，对绵羊诊断的需求正在稳步增长。该细分市场的增长趋势受到几个关键驱动因素的影响。对牲畜健康和生物安全的关注，加上旨在根除疾病的政府支持政策，正在推动对所有动物类型的诊断的需求。牛的诊断继续主导市场，但随着教育活动强调早期检测对改善牛群健康的重要性，羊也迅速获得关注。先进诊断技术的日益采用也促进了这一增长趋势。

牛（主导）与羊（新兴）

由于约尼氏病在牛群中的发病率很高，因此牛的约尼氏病诊断仍然在市场上占据主导地位。许多养牛场制定了定期检测协议，促进了对诊断解决方案的持续需求。牛诊断市场的特点是兽医服务提供商和养牛场之间建立了良好的关系，确保一致的参与。另一方面，绵羊诊断被认为是一个正在加速增长的新兴领域。随着人们越来越认识到约尼氏病对羊毛和肉类生产的影响，养羊户越来越多地寻求有效的诊断工具。随着新技术和可用的测试选项增强了羊诊断的吸引力，市场动态正在发生变化。这些因素的结合使绵羊成为约翰病管理中日益受到关注的问题。

### 按最终用户：兽医诊所（最大）与诊断实验室（增长最快）

在约翰氏病诊断市场中，兽医诊所在最终用户领域占据主导地位，由于其在牲畜这种疾病的初步诊断和治疗中发挥着至关重要的作用，因此占据了相当大的份额。他们提供即时检测和诊断服务，这对于有效管理和控制约尼氏病至关重要。诊断实验室紧随其后，在确认诊所诊断和支持研究计划方面发挥着至关重要的作用。该部分还提供了广泛的先进测试，可以指导治疗策略。

兽医诊所（主导）与研究机构（新兴）

兽医诊所在约翰氏病诊断市场中至关重要，提供满足牲畜所有者和农民需求的直接服务。他们的成功源于他们的可及性和及时提供诊断的能力，这可以显着影响牛群健康管理。另一方面，研究机构代表了该市场中的新兴部分，专注于先进诊断技术和技术的研究和开发。这些研究所有助于更广泛地了解约翰氏病，旨在创新解决方案，提高诊断能力并改善兽医实践的结果。

### 按分销渠道：在线药店（最大）与直销（增长最快）

在约翰氏病诊断市场中，渠道之间的分布显示市场份额存在显着差异。在线药店占据了最大的份额，利用了医疗保健领域对数字解决方案日益增长的偏好。它们广泛的覆盖范围和便利性使其成为许多消费者的首选。相反，直销正在成为一个重要的渠道，由于直接面向兽医专业人士和农业利益相关者，确保快速获得诊断工具，因此其份额稳步增加。

网上药店（主导）与直销（新兴）

在线药店通过提供来自值得信赖的制造商的全系列诊断产品，主导着约翰氏病诊断市场。他们的便利性，加上提供专业咨询的能力，使他们在市场中具有战略地位。另一方面，直销正在成为一股新兴力量，特别是对于寻求个性化服务和即时供应诊断工具的兽医诊所而言。这种模式允许供应商和兽医之间建立更深层次的关系，使其成为越来越受欢迎的渠道，特别是在获得在线服务可能受到限制的农村地区。

## Regional Market Share Analysis

### 北美：诊断的领先市场

北美是约翰氏病诊断的最大市场，占全球市场份额的约45%。该地区受益于先进的兽医医疗系统、对约翰氏病的养殖者意识的提高，以及促进早期检测和管理的严格监管框架。对有效诊断工具的需求进一步受到养殖业生产增加和疾病控制措施需求的推动。

美国和加拿大是该市场的领先国家，主要参与者如IDEXX Laboratories、Neogen Corporation和Zoetis在此建立了强大的存在。竞争格局的特点是关键参与者之间持续的创新和合作，以增强诊断能力。预计对研究和开发的关注将在未来几年进一步推动市场增长。

### 欧洲：对动物健康的监管关注

欧洲在约翰氏病诊断市场上正经历显著增长，约占全球市场份额的30%。该地区的增长受到旨在改善动物健康和福利的严格法规的推动，同时对约翰氏病对养殖生产力经济影响的意识也在提高。欧盟加强生物安全措施和疾病管理的倡议是市场扩展的关键催化剂。

该地区的领先国家包括德国、法国和英国，主要参与者如QIAGEN和Bio-Rad Laboratories积极参与其中。竞争格局的特点是公共和私营部门之间的合作，以开发创新的诊断解决方案。对研究和开发的重视，加上对可持续养殖实践的日益关注，预计将进一步推动欧洲市场的增长。

### 亚太地区：新兴市场潜力

亚太地区正迅速崛起为约翰氏病诊断市场的重要参与者，约占全球市场份额的20%。增长受到养殖生产增加、对动物疾病意识提高以及政府旨在改善兽医医疗的倡议的推动。澳大利亚和印度等国在此方面处于领先地位，对有效诊断工具的需求不断增长，以管理养殖健康。

澳大利亚是Genetic Technologies等主要参与者的所在地，而印度则见证了本地公司进入市场的激增。竞争格局正在演变，重点是可负担和可及的诊断解决方案。随着该地区继续投资于兽医基础设施和教育，市场在未来几年有望实现显著增长。

### 中东和非洲：未开发的市场机会

中东和非洲地区代表了一个未开发的约翰氏病诊断市场，约占全球市场份额的5%。增长潜力受到养殖活动增加和对动物健康问题意识提高的推动。政府旨在改善农业实践和兽医服务的倡议预计将催化该地区市场的发展。

南非和肯尼亚等国处于前沿，本地参与者开始在诊断领域崭露头角。竞争格局的特点是国际和地区公司混合，努力满足对有效诊断解决方案日益增长的需求。随着对兽医医疗的投资增加，市场可能会在诊断技术和服务方面看到显著进展。

## Competitive Benchmarking

约翰氏病诊断市场的特点是竞争格局日益受到创新、战略合作伙伴关系和区域扩张的影响。 IDEXX Laboratories（美国）、Neogen Corporation（美国）和 Zoetis（美国）等主要参与者处于领先地位，利用其技术能力提高诊断准确性和效率。 IDEXX Laboratories（美国）通过持续投资研发，专注于满足兽医和牲畜生产者不断变化的需求的先进诊断解决方案，将自己定位为领导者。与此同时，Neogen Corporation（美国）强调扩大其产品组合的战略，其中包括集成数字工具以简化测试流程，从而提高客户参与度和满意度。 Zoetis（美国）采取了更为积极的策略，重点通过战略收购来增强市场占有率并扩大其诊断产品范围，从而共同塑造了一个充满活力和多元化的竞争环境。在商业策略方面，企业越来越多地实现制造本地化和优化供应链，以提高运营效率并降低成本。市场结构较为分散，多家企业争夺市场份额，但大公司的影响力很大。这种竞争结构允许提供多样化的诊断解决方案，满足畜牧业的各个细分市场，同时还通过竞争促进创新。
8月，IDEXX实验室（美国）宣布推出专为约内氏病设计的新型快速检测试剂盒，预计将显着缩短诊断所需时间。这一战略举措不仅增强了 IDEXX 的产品供应，还强化了其为兽医提供及时解决方案的承诺，从而有可能增加其在诊断领域的市场份额。该套件的推出符合畜牧业对快速可靠诊断工具不断增长的需求。
7 月，Neogen Corporation（美国）与一家领先的农业技术公司建立了合作伙伴关系，开发一个将诊断测试与数据分析相结合的集成平台。这种合作有望彻底改变畜牧生产者管理牛群健康的方式，因为它允许根据诊断结果进行实时监控和决策。这种战略联盟表明疾病管理正在转向更全面的方法，这可以增强 Neogen 在市场上的竞争优势。
9月，硕腾（美国）完成了对一家专门从事牲畜疾病分子诊断（包括约翰氏病）的生物技术公司的收购。此次收购具有战略意义，因为它不仅扩大了硕腾的诊断能力，还增强了其研发管线。通过整合先进的分子技术，硕腾有可能提高疾病检测的准确性和速度，从而巩固其市场领导者的地位。
截至 10 月，约内病诊断市场当前的竞争趋势越来越多地由数字化、可持续性和人工智能集成来定义。公司正在组建战略联盟，以增强技术能力并提高诊断准确性。竞争格局正在从传统的价格竞争转向关注创新、技术和供应链可靠性。这种演变表明，未来的差异化将取决于提供先进、可靠的诊断解决方案的能力，以满足畜牧业不断增长的需求。

## Recent News & Developments

约翰氏病诊断市场的最新发展表明，关键行业参与者在提高诊断能力方面取得了显著进展和日益增长的兴趣。IDEXX实验室和Zoetis等公司正在积极增强其检测解决方案，以提供更快、更准确的约翰氏病诊断。此外，Epitopix和默克动物健康公司专注于开发创新的血清学检测，这对早期检测和管理策略至关重要。

最近的市场动态突显了QIAGEN和赛默飞世尔科技等公司的投资增加，推动了分子诊断技术的进步。此外，BioRad实验室和Neogen公司正在探索合作机会，以开发全面的检测产品组合。

在并购方面，许多公司通过战略合作伙伴关系扩大其诊断能力，增强其在市场上的存在。这种持续的整合预计将提升他们的技术产品，并扩大他们的市场覆盖范围。约翰氏病诊断市场的整体增长和投资反映了对动物健康和食品安全的高度关注，这种关注是由于对该疾病在牲畜生产中所带来的经济影响的日益认识。

## Report Scope

| 2024年市场规模 | 0.7901（十亿美元） |
| --- | --- |
| 2025年市场规模 | 0.839（十亿美元） |
| 2035年市场规模 | 1.528（十亿美元） |
| 复合年增长率（CAGR） | 6.18%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 分子诊断的进步增强了约翰氏病诊断市场的早期检测能力。 |
| 主要市场动态 | 对准确诊断的需求上升推动了约翰氏病检测技术的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，约翰氏病诊断市场的预计市场估值是多少？**
A: 约翰氏病诊断市场预计到2035年将达到15.28亿美元的估值。

**Q: 2024年约翰氏病诊断市场的市场估值是多少？**
A: 在2024年，市场估值为7.901亿美元。

**Q: 在2025年至2035年的预测期内，约翰氏病诊断市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，约翰氏病诊断市场的预期CAGR为6.18%。

**Q: 2024年哪个测试类型细分的估值最高？**
A: 在2024年，血清学检测部门的估值最高，达到0.2501亿美元。

**Q: 2024年PCR检测市场与培养检测市场相比如何？**
A: 在2024年，PCR检测部门的估值为2亿美元，而培养检测部门的估值为1.5亿美元。

**Q: 到2035年，牛肉板块的预计估值是多少？**
A: 到2035年，牛肉板块预计将达到7.856亿美元的估值。

**Q: 到2035年，预计哪个分销渠道将显示显著增长？**
A: 零售药房分销渠道预计到2035年将增长至0.5888亿美元。

**Q: 兽医诊所在约翰氏病诊断市场中扮演什么角色？**
A: 预计到2035年，兽医诊所的市场估值将达到6.345亿美元。

**Q: 哪些关键参与者正在引领约翰氏病诊断市场？**
A: 市场上的主要参与者包括IDEXX Laboratories、Neogen Corporation和Zoetis等。

**Q: 未来几年约翰氏病诊断市场的预期增长趋势是什么？**
A: 约翰氏病诊断市场预计将经历稳定增长，预计在2025年至2035年期间的年均增长率（CAGR）为6.18%。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/johnes-disease-diagnostic-market-32693*